Results 201 to 210 of about 11,994 (242)
Some of the next articles are maybe not open access.
Drugs, 2004
Micafungin, an echinocandin antifungal agent with a novel mechanism of action, inhibits beta-(1,3)-D-glucan synthase interfering with fungal cell wall synthesis. It shows excellent antifungal activity against a broad range of Candida spp., including azole-resistant strains, and Aspergillus spp. in in vitro and animal studies.
Blair Jarvis +2 more
+11 more sources
Micafungin, an echinocandin antifungal agent with a novel mechanism of action, inhibits beta-(1,3)-D-glucan synthase interfering with fungal cell wall synthesis. It shows excellent antifungal activity against a broad range of Candida spp., including azole-resistant strains, and Aspergillus spp. in in vitro and animal studies.
Blair Jarvis +2 more
+11 more sources
Anti-Candida auris activity in vitro and in vivo of micafungin loaded nanoemulsions.
Medical Mycology, 2022Fungi are becoming increasingly resistant, especially the new strains. Therefore, this work developed nanoemulsions (NE) containing micafungin (MICA), in order to improve its action against infections caused by Candida auris. The NEs were composed by the
G. Marena +4 more
semanticscholar +1 more source
Expert Opinion on Pharmacotherapy, 2022
Introduction Invasive candidiasis remains a leading cause of morbidity and mortality in various categories of patients at risk. Areas covered Structure and mechanism of action, pharmacokinetics and pharmacodynamics, clinical studies, safety, and ...
M. Bassetti +3 more
semanticscholar +1 more source
Introduction Invasive candidiasis remains a leading cause of morbidity and mortality in various categories of patients at risk. Areas covered Structure and mechanism of action, pharmacokinetics and pharmacodynamics, clinical studies, safety, and ...
M. Bassetti +3 more
semanticscholar +1 more source